UK markets closed

Aldeyra Therapeutics, Inc. (ALDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.2400+0.0800 (+1.92%)
As of 09:37AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts8885
Avg. Estimate-0.13-0.15-0.2-0.43
Low estimate-0.17-0.19-0.72-0.8
High estimate-0.08-0.081.150.55
Year ago EPS-0.15-0.14-0.64-0.2
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3354
Avg. EstimateN/AN/A39.8M51.71M
Low estimateN/AN/AN/A18.7M
High estimateN/AN/A100M100M
Year ago salesN/AN/AN/A39.8M
Sales growth (year/est)N/AN/AN/A29.90%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.31-0.24-0.14-0.11
Actual EPS-0.15-0.14-0.08-0.14
Difference0.160.10.06-0.03
Surprise %51.60%41.70%42.90%-27.30%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.13-0.15-0.2-0.43
7 days ago-0.13-0.15-0.19-0.29
30 days ago-0.13-0.15-0.19-0.41
60 days ago0.88-0.29-0.15-0.68
90 days ago0.88-0.29-0.15-0.68
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1221
Growth estimatesALDXIndustrySector(s)S&P 500
Current qtr.13.30%N/AN/AN/A
Next qtr.-7.10%N/AN/AN/A
Current year68.80%N/AN/AN/A
Next year-115.00%N/AN/AN/A
Next 5 years (per annum)73.70%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A